- Home
- MDRR vs IPA Comparison
MDRR vs IPA Comparison
Compare MDRR & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- IPA
- Stock Information
- Founded
- MDRR 2015
- IPA 1983
- Country
- MDRR United States
- IPA Canada
- Employees
- MDRR N/A
- IPA N/A
- Industry
- MDRR Real Estate Investment Trusts
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- MDRR Real Estate
- IPA Health Care
- Exchange
- MDRR Nasdaq
- IPA Nasdaq
- Market Cap
- MDRR 13.9M
- IPA 15.3M
- IPO Year
- MDRR 2018
- IPA 2017
- Fundamental
- Price
- MDRR $12.25
- IPA $0.67
- Analyst Decision
- MDRR
- IPA Strong Buy
- Analyst Count
- MDRR 0
- IPA 2
- Target Price
- MDRR N/A
- IPA $5.00
- AVG Volume (30 Days)
- MDRR 3.8K
- IPA 422.7K
- Earning Date
- MDRR 03-05-2025
- IPA 03-13-2025
- Dividend Yield
- MDRR 1.79%
- IPA N/A
- EPS Growth
- MDRR N/A
- IPA N/A
- EPS
- MDRR N/A
- IPA N/A
- Revenue
- MDRR $9,916,929.00
- IPA $17,272,336.00
- Revenue This Year
- MDRR N/A
- IPA $1.88
- Revenue Next Year
- MDRR N/A
- IPA $9.90
- P/E Ratio
- MDRR N/A
- IPA N/A
- Revenue Growth
- MDRR N/A
- IPA 6.36
- 52 Week Low
- MDRR $9.84
- IPA $0.33
- 52 Week High
- MDRR $15.00
- IPA $2.60
- Technical
- Relative Strength Index (RSI)
- MDRR 43.55
- IPA 78.39
- Support Level
- MDRR $12.20
- IPA $0.43
- Resistance Level
- MDRR $12.52
- IPA $0.59
- Average True Range (ATR)
- MDRR 0.23
- IPA 0.08
- MACD
- MDRR -0.13
- IPA 0.03
- Stochastic Oscillator
- MDRR 13.00
- IPA 93.09
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged in the acquisition, reposition, renovation, leasing, and managing of income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its principal objectives include sourcing value-added Investments in markets in which it maintains deep industry relationships and local market knowledge and the creation of value for stockholders by utilizing its relationships and local knowledge of commercial real estate investment, management, and disposition.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.